KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Amgen (AMGN) Cost of Revenue (2016 - 2026)

Amgen has reported Cost of Revenue over the past 18 years, most recently at $2.7 billion for Q1 2026.

  • For Q1 2026, Cost of Revenue fell 7.55% year-over-year to $2.7 billion; the TTM value through Mar 2026 reached -$1.8 billion, down 119.67%, while the annual FY2025 figure was $1.3 billion, 89.8% down from the prior year.
  • Cost of Revenue for Q1 2026 was $2.7 billion at Amgen, up from -$7.7 billion in the prior quarter.
  • Over five years, Cost of Revenue peaked at $3.2 billion in Q2 2024 and troughed at -$7.7 billion in Q4 2025.
  • A 5-year average of $1.3 billion and a median of $1.7 billion in 2022 define the central range for Cost of Revenue.
  • On a YoY basis, Cost of Revenue climbed as much as 4240.85% in 2025 and fell as far as 349.0% in 2025.
  • Year by year, Cost of Revenue stood at $1.7 billion in 2022, then soared by 78.13% to $3.1 billion in 2023, then changed by 0.0% to $3.1 billion in 2024, then plummeted by 349.0% to -$7.7 billion in 2025, then soared by 135.41% to $2.7 billion in 2026.
  • Business Quant data shows Cost of Revenue for AMGN at $2.7 billion in Q1 2026, -$7.7 billion in Q4 2025, and $3.1 billion in Q3 2025.